Abstract
Background. Generalised osteoporosis is often described in patients with rheumatoid arthritis (RA). The (Ann Rheum Dis 1993; 52: [21] [22] [23] [24] [25] [26] The pathogenesis of axial osteopenia in patients with rheumatoid arthritis (RA) is poorly understood. As in patients without RA, age, sex, height, weight, parity, time since the menopause, drinking and smoking history, and some dietary habits may affect bone mineral density (BMD).' In addition, several factors specifically related to RA could also be important. Most often the duration of the disease, the degree of functional impairment, and the severity of the inflammatory process have been suggested as potential risk factors for osteoporosis in patients with RA.
Most previous studies have had a cross sectional design. A negative association between duration of RA and BMD was found in some of these studies,2 3 but has not been confirmed by others. 8 The degree of functional impairment has been sugested as an important risk factor for fracture by some workers,9 10 but not by all. 1 A negative association between the latter factor and BMD has been described,2 7 and denied.4 6 8 Disease activity has also been suggested as a possible risk factor for osteopenia in patients with rheumatoid arthritis.3 " Other workers found no such association. '2 As many, often interdependent, factors may contribute to the development of osteoporosis in patients with RA, the influence of one specific factor is difficult to evaluate, and the effect of potentially confounding factors on the results should be corrected for. So far, no study has included all the suggested disease related risk factors in an analysis suitable for the evaluation of the influence of multiple factors on BMD. Furthermore, these studies have only assessed potential risk factors such as degree of functional impairment and activity of RA at the time when the BMD was measured. It may be expected, however, that their effects will only become apparent after a sufficiently long period of time. Therefore these data should be interpreted with restraint. In our department, disease activity and functional capacity are studied prospectively in all patients with recent onset RA. These data were used to study the influence of RA related factors on axial BMD.
Patients and methods

PATIENTS
Since 1985 all patients presenting to the rheumatology outpatient clinic of the University Hospital Nijmegen with recent onset RA have been asked to participate in a long term prospective follow up study. All patients included in this study had classical or definite RA,'3 had had symptoms for less than one year, and had not been treated with disease modifying antirheumatic drugs before inclusion in the study. At the start of the present investigation 147 patients were participating in the long term prospective follow up. All patients were asked to participate in the present study.
prospectively assessed in all participating patients by specially trained research nurses. Measures of disease activity were assessed at least once every three months. For the present study only three monthly assessments were used. Functional capacity was assessed once every six months.
Measures of disease activity included the number of tender joints, the number of swollen joints, the Disease activity was evaluated prospectively by different parameters as described earlier. In previous reports on the prospective follow up study, the Ritchie articular index, the number of swollen joints, the ESR, and the degree of general health were found to best reflect different aspects of disease activity. A combined disease activity score, consisting of those parameters, was also constructed. 7 18 In the present study we limited the analysis to the disease activity score and its four constituents. We first inspected plots between BMD and each of the variables reflecting disease activity. Initially, only those assessments carried out at approximately the same time as densitometry were used. We then repeatedly extended backwards the observation period with three month intervals, plotting the mean value of the disease activity score and each of the four constituting parameters against BMD, and the observation period with the best linear association between disease activity and BMD was selected.
A similar procedure was carried out for defining functional capacity. We plotted the health assessment questionnaire scores against BMD, and used six instead of three month intervals for the backwards extension of the observation period.
The influence of duration of RA, disease activity, and functional capacity on BMD was then evaluated by multiple linear regression analysis. The results obtained with dual energy x ray absorptiometry in the lumbar spine, the combined region in the hip, and in Ward's triangle were used as dependent variables. The independent variables included age (years), gender (0=male, 1=female), body mass index (kg/m2), duration of RA (months), and disease activity and functional capacity as defined according to the procedures described above. In a subgroup of female patients the duration of time since the menopause (years) and parity (number of children) were also included among the independent variables. The regression analysis was carried out both with and without model selection techniques. Model selection was carried out by stepwise regression. In this analysis variables were added one by one to the model if they contributed to the BMD with p!0 15. After adding a variable, all variables already included in the model were re-evaluated and deleted if they no longer contributed to the BMD with p<0 15. We also checked whether the models finally selected best explained the variation in BMD by calculating R2 (adjusted for the number of variables) for all possible models.
The relation between BMD on the one hand, and the various independent variables on the other, is described in three regression equations for each skeletal region separately. The proportion of variance of BMD explained by the regression equation is indicated by R2, which has also been calculated after correction for the number of variables in the equation (R2(adjusted) ). The influence of the independent variables selected for the model on BMD is described in further detail by providing the parameter estimate, its 95% confidence interval, and the probability for testing the null hypothesis that the parameter estimate is not significantly different from zero. detailed clinical data on the participating patients. In those patients receiving prednisone the daily dose never exceeded 10 mg/day. The median duration of glucocorticoid treatment was 1-4 years (range 0-2-2-7 years). Tables 2 and 3 summarise the BMD data. Lumbar BMD was measured in all 97 patients. In six patients no measurements could be performed in the hips because of bilateral joint replacement. Z scores tended to be negative in our patients, indicating a decrease in mean BMD compared with the data of a normal age and sex matched reference population supplied by the manufacturer. The mean Z score was positive only for the lumbar spine in female patients. The proportion of patients with a low BMD (table 3) was consistently higher than expected.
In the plots between BMD and the parameters reflecting disease activity, no association was seen for any of the observation periods between the BMD and Ritchie articular index, number of swollen joints, degree of general health, or the combined disease activity score. A negative linear association was suggested between the ESR and BMD for simultaneous measurements. When extending the observation period backwards, the association between ESR and BMD improved and was judged to be optimum for a period of six months preceding bone mineral densitometry. Gradual worseningofthe observed association resulted from extending the observation period further backwards. For the purpose of the present study disease activity was then defined as the mean ESR in the six months before bone mineral densitometry (mean ES&).
In the plots between BMD and health assessment questionnaire scores a linear association was suggested for simultaneous assessments. The association was judged to be optimum for an observation period of 18 months before densitometry. For the purpose of the present study functional capacity was then defined as the mean health assessment questionnaire score in the 18 months preceding BMD measurement (mean HAQ,8).
Multiple linear regression analysis was carried out first using the data of all patients together. The following models were reached with the stepwise regression analysis: Table 4 gives detailed information on the parameter estimates.
When Z scores were used as the dependent variable, similar results were reached with respect to the influence of duration of RA, mean ESR6, and mean HAQ18. In an attempt to exclude patients with false increases in lumbar BMD due to severe degenerative spinal changes, we checked the images produced by the Hologic bone densitometer for the presence of osteophytes. Patients who had less than two vertebrae with marked osteophytes were analysed separately. The 95% confidence intervals for the parameter estimates were -6-68 to -2 05 for age (p=0003), -4-89 to -0-71 for duration of RA (p=0 009), and -0 07 to +[ 76 for body mass index (p=007).
Further analysis showed that the models resulting from the stepwise regression analysis were also those with the highest R2 value, after adjustment for the number ofvariables included.
Multiple linear regression analysis was also performed in subgroups of premenopausal and postmenopausal women, and in male patients. The parameter estimates for disease duration, ESR6, HAQ18, and body mass index were almost identical and not significantly different between those three subgroups. Prednisone treatment affected BMD in the combined region of the hip only in postmenopausal women (estimated influence of prednisone treatment -0-088, 95% confidence interval from -0-167 to -0-008; p=0 03). The age related decrease in BMD was significantly greater in postmenopausal women than in premenopausal women or in male patients, both in the lumbar spine and in the hip areas (p<0 01 for all skeletal regions).
In postmenopausal women a separate analysis was carried out including time since the menopause and parity among the independent variables. Age and time since the menopause were highly correlated. Time since the menopause was included instead of age in the model for the lumbar spine and for the combined region in the hip. Age was selected for the model for Ward's triangle, and time since the menopause was not included. Parity was included only in the model for lumbar BMD (parameter estimate +0-022, 95% confidence interval from -0 003 to +0-048; p=0.09). The inclusion of time since the menopause and parity among the independent variables in the analysis did not significantly change the estimates for duration of RA, mean ESR6, mean HAQ18, use of prednisone, and body mass index.
Discussion
This study was designed to evaluate the influence of certain disease characteristics on axial bone mass in RA. For this purpose we used prospectively assessed measures of functional impairment and of activity of the inflammatory process, and we measured BMD in the lumbar spine and in the hips of patients with recent onset RA.
A negative association between duration of RA and BMD was found in three skeletal regions. This has been described by some, but not all, previous workers.28 Our data suggest that RA dependent mechanisms cause a gradual decrease in bone mass within the first five years of the disease in the axial skeleton.
The degree of physical activity is generally recognised as a determinant of BMD. Extreme inactivity causes rapid bone loss, whereas athletes have a higher BMD than sedentary subjects. Exercise intervention programmes have shown reduced bone loss or increased bone mass.20 21 In patients with RA impaired functional capacity and reduced physical activity have been associated with a decrease in bone mass and an increase in fracture risk in some cross sectional studies.2 7 9 10 None of these studies included prospective data on functional capacity or disease activity. Our data show that the degree of functional impairment, expressed by the mean value of the health assessment questionnaire score in the last 18 months, is related to BMD in the hip areas, even after correction for differences in ESR.
The level of activity of the inflammatory process has also been suggested as a determinant of BMD in patients with RA in some cross sectional studies.3 4 Our data show that some but not all measures of disease activity may be related to femoral BMD. The mean ESR in the last six months was negatively associated with BMD in the hip areas. This association was no longer present when the observation period was extended over six months before densitometry, suggesting that only recent disease activity is important for BMD. Other measures of disease activity, including the Ritchie articular index, the number of swollen joints, and the degree of general health, were not related to BMD. The data suggest that the acute phase response may be associated with a release of factors that affect bone metabolism. Probable candidates are cytokines such as interleukin 1 Stepwise regression analysis in the resulting subgroup showed an approximately twofold improvement of R2 for the lumbar spine. Sex, mean ESR, and mean health assessment questionnaire score, however, still had no effect on spinal BMD. We conclude that our lumbar BMD data should be cautiously interpreted.
The regression analysis was performed in the two sexes combined. No significant differences were observed in the estimated influence of duration of RA, degree of functional impairment, or level of disease activity, between the sexes or between pre-and postmenopausal women. The number of patients in each subgroup is small, however, and differences cannot actually be excluded. In postmenopausal women multiparity exerted a protective effect on BMD in the spine, as was previously described by Sambrook et al. 7 No effect of prednisone on BMD could be shown except in postmenopausal women. Data on the influence of low dose glucocorticoids on bone mass in patients with RA are controversial. 25 The present study was not designed to evaluate the possible contribution of this drug to the development of osteoporosis, and the number of patients using prednisone in the study is too small to allow conclusions on this topic. The data presented in this paper support the hypothesis that BMD may be affected by RA related mechanisms. This may lead to a decreased BMD in patients with RA versus normal controls. We cannot, however, definitely confirm this hypothesis, as our study did not include normal controls. Instead, Z scores were calculated after comparison with reference values supplied by the manufacturer. For this data set measurements were carried out in 950 (spine) and 1500 (hip) North American subjects. Reference data accumulated in France, Belgium, and Australia correlate closely with these North American values, within ±2% over the whole BMD range for spinal measurements.26 Furthermore, 60 healthy women who participated in a trial aimed at the prevention of postmenopausal bone loss were measured in our hospital. Baseline measurements in these patients confirm the validity of the Hologic normal data for Dutch women aged between 40 and 60. Mean Z scores in our study were negative with the exception of the Z score for the lumbar spine in female patients. After exclusion of patients with suspected severe degenerative spinal changes, Z scores were also negative in this subgroup. The proportion of patients with a low bone mass was consistently higher in our patients than expected. Taken together our data suggest that BMD may be decreased in a subset of patients with recent onset RA, with active disease and functional disabilities.
Although clinical parameters were collected prospectively in our study, BMD was measured only once. Sambrook et al 27 have previously prospectively studied a small number of patients with recent onset RA. Over a period of one to two years increased bone loss was shown at the distal radius, but not at the proximal radius or the lumbar spine. 
